33
/pt/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
3512552
319423
2
Public Timelines
FAQ Receber premium

1 jan 1998 ano - Trastuzumab

Descrição:

For the treatment of women with HER2-positive metastatic breast cancer, the Food and Drug Administration (FDA) recommends trastuzumab, a monoclonal antibody that inhibits cancer cells that overproduce the HER2 protein.

Adicionado na linha do tempo:

14 nov 2019
0
0
302

Data:

1 jan 1998 ano
Agora
~ 27 years ago